Literature DB >> 25567136

Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma.

M P Purdue1, Q Lan2, T J Kemp3, A Hildesheim2, S J Weinstein2, J N Hofmann2, J Virtamo4, D Albanes2, L A Pinto3, N Rothman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25567136      PMCID： PMC5432037          DOI： 10.1038/leu.2015.2

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.

Authors:  Mark P Purdue; Qing Lan; Rachel Bagni; William G Hocking; Dalsu Baris; Douglas J Reding; Nathaniel Rothman
Journal:  Cancer Res       Date:  2011-06-01       Impact factor: 12.701

Review 2.  CD23 and B cell activation.

Authors:  J Gordon
Journal:  Clin Exp Allergy       Date:  1992-02       Impact factor: 5.018

Review 3.  Clinical aspects of monoclonal B-cell lymphocytosis.

Authors:  Yvonne M Mowery; Mark C Lanasa
Journal:  Cancer Control       Date:  2012-01       Impact factor: 3.302

4.  Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.

Authors:  Yian Gu; Roy E Shore; Alan A Arslan; Karen L Koenig; Mengling Liu; Sherif Ibrahim; Anna E Lokshin; Anne Zeleniuch-Jacquotte
Journal:  Cancer Causes Control       Date:  2010-04-07       Impact factor: 2.506

Review 5.  Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2003-08       Impact factor: 53.106

6.  Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma.

Authors:  Anneclaire J De Roos; Dana K Mirick; Kerstin L Edlefsen; Andrea Z LaCroix; Kenneth J Kopecky; Margaret M Madeleine; Larry Magpantay; Otoniel Martínez-Maza
Journal:  Cancer Res       Date:  2012-07-30       Impact factor: 12.701

7.  The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group.

Authors: 
Journal:  Ann Epidemiol       Date:  1994-01       Impact factor: 3.797

8.  Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation.

Authors:  S Fournier; M Rubio; G Delespesse; M Sarfati
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

9.  A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma.

Authors:  Mark P Purdue; Qing Lan; Otoniel Martinez-Maza; Martin M Oken; William Hocking; Wen-Yi Huang; Dalsu Baris; Betty Conde; Nathaniel Rothman
Journal:  Blood       Date:  2009-07-28       Impact factor: 22.113

10.  Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines.

Authors:  G Del Prete; M De Carli; F Almerigogna; C K Daniel; M M D'Elios; G Zancuoghi; F Vinante; G Pizzolo; S Romagnani
Journal:  FASEB J       Date:  1995-01       Impact factor: 5.191
View more
  10 in total

1.  Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.

Authors:  Mark P Purdue; Qing Lan; Judith Hoffman-Bolton; Allan Hildesheim; Catherine L Callahan; Paul Strickland; Kala Visvanathan; Nathaniel Rothman
Journal:  Int J Cancer       Date:  2018-12-19       Impact factor: 7.396

2.  Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.

Authors:  Marta Epeldegui; Otoniel Martínez-Maza
Journal:  For Immunopathol Dis Therap       Date:  2015

3.  Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.

Authors:  Danielle M Carrick; Anil K Chaturvedi; Meredith S Shiels; Rao L Divi; Kelly K Filipski; Elizabeth F Hebert; Mukesh Verma; Allan Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-24       Impact factor: 4.254

4.  Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts.

Authors:  Bryan A Bassig; Xiao-Ou Shu; Woon-Puay Koh; Yu-Tang Gao; Mark P Purdue; Lesley M Butler; Jennifer Adams-Haduch; Yong-Bing Xiang; Troy J Kemp; Renwei Wang; Ligia A Pinto; Tongzhang Zheng; Bu-Tian Ji; H Dean Hosgood; Wei Hu; Gong Yang; Heping Zhang; Wong-Ho Chow; Christopher Kim; Wei Jie Seow; Wei Zheng; Jian-Min Yuan; Qing Lan; Nathaniel Rothman
Journal:  Int J Cancer       Date:  2015-06-26       Impact factor: 7.396

5.  Potential Utility of Systemic Plasma Biomarkers for Evaluation of Pediatric Schistosomiasis in Western Kenya.

Authors:  Bartholomew N Ondigo; Rachael E Hamilton; Edwin O Magomere; Isaac O Onkanga; Pauline N Mwinzi; Maurice R Odiere; Lisa Ganley-Leal
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 6.  AllergoOncology - the impact of allergy in oncology: EAACI position paper.

Authors:  E Jensen-Jarolim; H J Bax; R Bianchini; M Capron; C Corrigan; M Castells; D Dombrowicz; T R Daniels-Wells; J Fazekas; E Fiebiger; S Gatault; H J Gould; J Janda; D H Josephs; P Karagiannis; F Levi-Schaffer; A Meshcheryakova; D Mechtcheriakova; Y Mekori; F Mungenast; E A Nigro; M L Penichet; F Redegeld; L Saul; J Singer; J F Spicer; A G Siccardi; E Spillner; M C Turner; E Untersmayr; L Vangelista; S N Karagiannis
Journal:  Allergy       Date:  2017-01-23       Impact factor: 13.146

7.  Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.

Authors:  Roel Vermeulen; Fatemeh Saberi Hosnijeh; Barbara Bodinier; Lützen Portengen; Benoît Liquet; Javiera Garrido-Manriquez; Henk Lokhorst; Ingvar A Bergdahl; Soterios A Kyrtopoulos; Ann-Sofie Johansson; Panagiotis Georgiadis; Beatrice Melin; Domenico Palli; Vittorio Krogh; Salvatore Panico; Carlotta Sacerdote; Rosario Tumino; Paolo Vineis; Raphaële Castagné; Marc Chadeau-Hyam; Maria Botsivali; Aristotelis Chatziioannou; Ioannis Valavanis; Jos C S Kleinjans; Theo M C M de Kok; Hector C Keun; Toby J Athersuch; Rachel Kelly; Per Lenner; Goran Hallmans; Euripides G Stephanou; Antonis Myridakis; Manolis Kogevinas; Lucia Fazzo; Marco De Santis; Pietro Comba; Benedetta Bendinelli; Hannu Kiviranta; Panu Rantakokko; Riikka Airaksinen; Paivi Ruokojarvi; Mark Gilthorpe; Sarah Fleming; Thomas Fleming; Yu-Kang Tu; Thomas Lundh; Kuo-Liong Chien; Wei J Chen; Wen-Chung Lee; Chuhsing Kate Hsiao; Po-Hsiu Kuo; Hung Hung; Shu-Fen Liao
Journal:  Int J Cancer       Date:  2018-04-26       Impact factor: 7.396

Review 8.  Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies.

Authors:  Solomon B Makgoeng; Rachel S Bolanos; Christie Y Jeon; Robert E Weiss; Onyebuchi A Arah; Elizabeth C Breen; Otoniel Martínez-Maza; Shehnaz K Hussain
Journal:  JNCI Cancer Spectr       Date:  2019-03-05

Review 9.  The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma.

Authors:  H Dean Hosgood; Marc J Gunter; Neil Murphy; Thomas E Rohan; Howard D Strickler
Journal:  Front Oncol       Date:  2018-04-16       Impact factor: 6.244

10.  Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies.

Authors:  Mara M Epstein; Bernard Rosner; Elizabeth C Breen; Julie L Batista; Edward L Giovannucci; Larry Magpantay; Jon C Aster; Scott J Rodig; Kimberly A Bertrand; Francine Laden; Otoniel Martínez-Maza; Brenda M Birmann
Journal:  Haematologica       Date:  2018-06-21       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.